Navigation Links
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
Date:6/1/2009

cialized Therapeutics, Hematology/Cardiology and Oncology. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R) (sorafenib) tablets, a small molecule drug. For more information about Onyx, visit the company's website at www.onyx-pharm.com.

Forward-Looking Statements

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our annual and interim reports filed with the Frankfurt Stock Exchange. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

This news release also contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding the timing, progress and results of the clinical development, safety, regulatory processes, and commercialization efforts of Nexavar. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated. Reference should be made to Onyx's Annual Report on Form 10-K for the year ended December 31, 2008, filed with the Secur
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals, Inc.; Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
2. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
3. Bayer HealthCare Cleared to Acquire Citracal(R)
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
6. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
7. Bayer Temporarily Suspends Global Trasylol(R) Marketing
8. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
9. Bayer Plants Trees With Chartiers Valley Intermediate School Students, Provides Free Environmental Education Materials
10. Bayer Awards Making Science Make Sense Grant to Girl Scouts
11. Bayer HealthCare Pharmaceuticals and MedAssets Supply Chain Systems Sign a Three-Year Agreement for Magnevist(R) Magnetic Resonance Contrast Media
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 11, 2014 Los Angeles dental ... he uses mini and full mouth implants to replace ... feature that distinguishes dental implants from other tooth replacements: ... the crowns. This alone prevents the long-term complications of ... advantages related to comfort, appearance and systemic health. Mini ...
(Date:7/11/2014)... Maureen Salamon HealthDay Reporter ... the millions of women who can,t cough, sneeze or ... treatment that uses stem cells to regenerate weakened urethra ... found that injecting stem cells isolated from patients, own ... participants within a year. Stress incontinence affects ...
(Date:7/11/2014)... 11, 2014 Recent research findings regarding Fourth ... atmosphere, and how water affects human bodies. That was the ... during an interview on the Sharon Kleyne Hour Power of ... , Gerald Pollack, PhD, is a Professor of Bioengineering at ... Phase of Water (Ebner & Sons, 2013). , ...
(Date:7/11/2014)... WA (PRWEB) July 11, 2014 Shoulder ... the rate of return to play has not been ... the American Orthopaedic Society for Sports Medicine’s ( AOSSM ... NFL players is approximately 90 percent no matter what ... highlighted the success rate of return to play following ...
(Date:7/11/2014)... (ACL) reconstructions occur more than 200,000 times a year, ... new ligament may determine how long you stay in ... the Annual Meeting of the American Orthopaedic Society of ... highlight that in a young athletic population, allografts (tissue ... autografts (tissue harvested from the patient)," said Craig R. ...
Breaking Medicine News(10 mins):Health News:Dental Implant Dentist, Kevin Sands DDS, Now Uses Mini and Full Mouth Implants to Replace Missing Teeth 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 3Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 2Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 3Health News:Stabilizing Shoulder Surgery Helps NFL Players Return to the Game 2Health News:ACL reconstructions may last longer with autografts 2
... forced migrations, refugee crisis, large-scale rape of women in sub-Saharan ... that area is a myth. This is according to a ... published this week in the British medical journal The Lancet. ... conflict spread HIV infection in host communities; the reverse may ...
... that regular vaccination of infants against H. influenzae type ... and meningitis, could save innumerable children in Asia. ... online in The Pediatric Infectious Disease Journal, has established ... vaccine prevented more than one-third of acute pneumonia cases ...
... found that a new type of engineered drug may have ... ,The study by researchers at the Ohio State University Comprehensive ... ,The research has established that an engineered drug ... tube and early animal tests. ,The agent ...
... Abuse and Alcoholism (NIAAA), a part of the U.S. ... subtypes of alcoholism by analysing a national sample ... findings should help dispel the popular notion of the ... NIAAA Associate Director for Clinical and Translational Research. ...
... Anxiety disorders seem to afflict humans very early, not sparing even ... for anxiety disorders in New South Wales in Australia. ... figures released by Macquarie University's Anxiety Research Unit show. ... per cent compared to a rate of about 1 per ...
... revealed that the secret of his relatively wrinkle-free visage at the ... ,The slender rock star, notorious for his wild ... applies a special cream under his eyes in order to keep ... the Daily Express quotes him as saying. ,"I ...
Cached Medicine News:Health News:War Spreading AIDS a Myth-UNHCR 2Health News:Routine Hib Vaccination Could Save Innumerable Asian Children 2Health News:Routine Hib Vaccination Could Save Innumerable Asian Children 3Health News:New Engineered Drug Shows Promise in Treating Lymphocytic Leukaemia 2Health News:Researchers Identify Five Distinct Subtypes of Alcoholism 2Health News:Researchers Identify Five Distinct Subtypes of Alcoholism 3Health News:Anxiety Disorders Show in Tiny Tots 2
(Date:7/11/2014)... , July 11, 2014 ... Market Research "Endoscopy Devices Market (Endoscopes, Endoscopic Operative Devices, ... Growth, Trends and Forecast, 2013-2019" the global endoscopy devices ... and is expected to grow at a CAGR of ... value of USD 36.9 billion in 2019. ...
(Date:7/11/2014)... , July 11, 2014 ... visitors to Safety & Health Expo 2014 ... the move to London ... management attending exhibition.     ... http://photos.prnewswire.com/prnh/20140711/696892-a )      ...
(Date:7/10/2014)... NEWS, Virginia , 11. Juli ... Hersteller von Kameras für die molekulare ... (MBI/BSGI), hat heute die CE-Zulassung für ... dem CE-Zeichen kann Dilon das Produkt ... Vertriebsbereich auf den Großteil der europäischen ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2
Idophor PVP Scrub Winged Sponges...
Triad Plus PVP-I Scrub Winged Sponges...
... preoperative skin preparation an ... site infections. Scrub Care brand ... offer high efficacy and safety ... Prevail-Fx offers the highest level ...
Single-dose applicator. Provides a superior, hands-off "friction scrub," enhancing the efficacy of the antiseptic solution it delivers....
Medicine Products: